Arbutus Biopharma Corp
SWB:I9DN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arbutus Biopharma Corp
SWB:I9DN
|
CA |
|
Godolphin Resources Ltd
ASX:OBT
|
AU |
|
Jadestone Energy PLC
LSE:JSE
|
SG |
|
Aecon Group Inc
TSX:ARE
|
CA |
|
Grid Dynamics Holdings Inc
NASDAQ:GDYN
|
US |
|
Ascopiave SpA
F:AVA
|
IT |
|
A
|
American Health Protection Corp
OTC:EWLL
|
US |
|
A
|
Arbutus Biopharma Corp
F:I9DN
|
CA |
Shareholder Yield
Current shareholder yield for 
I9DN is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
I9DN Price
Arbutus Biopharma Corp
| Average Annual Return | 6.77% |
| Standard Deviation of Annual Returns | 29.59% |
| Max Drawdown | -64% |
| Market Capitalization | 830.1m EUR |
| Shares Outstanding | 180 192 227 |
| Percentage of Shares Shorted |
N/A
|
